go back

Wyoming rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,047,129 · 10th–90th $562,341–$1,148,1540%20%40%10th90th$1,047,129Professionalmedian $645,654 · 10th–90th $549,541–$645,6540%50%10th$645,654$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$549,540.87 / $645,654.23 / $645,654.23
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$870,963.59 / $1,047,128.55 / $1,148,153.62
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $524,807.46 / $524,807.46